More news:
ubj: Mayor Willie Brown, Jr. Will Be Keynote Speaker at Bay Area Biomedical Investme
Date: 97-07-10 12:23:01 EDT
From: AOL News
BCC: Semcominc
SAN MATEO, Calif.--(BW HealthWire)--July 10, 1997--San
Francisco Bay Area biomedical companies will host The Bay Area
Biomedical Investment Conference July 28-30.
The invitation-only conference is held for buyside and sellside
analysts, institutional investors and portfolio managers. The
program will include comprehensive on-site visits to selected
biomedical companies and presentations at the Sheraton Palace Hotel
in San Francisco.
San Francisco Mayor Willie Brown, Jr. will be the keynote
luncheon speaker on Monday, July 28. He will discuss the
significance of the lifesciences industry to the Bay Area. In
addition, the luncheon will feature distinguished speaker Joan
Hamilton, who until recently was the Bay Area Bureau Chief for
Business Week. Hamilton is currently editor of Signals Magazine, an
on-line publication for the biotechnology industry. She will give
her perspective as a journalist who has covered the industry for the
last 15 years.
On Wednesday, July 30, the luncheon program will feature a panel
of renowned scientists discussing current biomedical research. Ed
Penhoet, Ph.D., President, Chief Executive Officer and Co-Founder of
Chiron Corp. will moderate the panel.
The panelists will include Stanley Cohen, M.D., the Kwoh-Ting Li
Professor of Genetics and Professor of Medicine at Stanford
University's School of Medicine, David Botstein, Ph.D., Professor and
Chairman of the Department of Genetics at Stanford University School
of Medicine, and Kasturi Haldar, Ph.D., Associate Professor in
Microbiology and Immunology in the Department of Microbiology and
Immunology at Stanford University. Dr. Cohen and his former
colleague Herbert Boyer are named as the inventors on the basic
patent covering the field of genetic engineering. Dr. Botstein's
research has centered on genetics, especially the use of genetic
methods to understand biological functions. Dr. Haldar's research
has focused on parasitology; she and her colleagues recently
identified a membrane network of the parasite that causes malaria,
which might provide a target for antimalaria drugs.
The coalition of companies hosting the conference includes Beacon
Diagnostics, Inc.; Cell Genesys, Inc. (Nasdaq:CEGE); Chiron Corp.
(Nasdaq:CHIR); Cholestech Corp. (Nasdaq:CTEC); Connetics Corp.
(Nasdaq:CNCT); Coulter Pharmaceutical Inc. (Nasdaq:CLTR); CV
Therapeutics, Inc. (Nasdaq:CVTX); FibroGen, Incorporated; Genelabs
Technologies, Inc. (Nasdaq:GNLB); Geron Corporation (Nasdaq:GERN);
Gryphon Sciences; InSite Vision, Incorporated (Nasdaq:INSV); LXR
Biotechnology, Inc. (AMEX:LXR); Matrix Pharmaceutical, Inc.
(Nasdaq:MATX); Microcide Pharmaceuticals (Nasdaq:MCDE); Molecular
Dynamics, Inc. (Nasdaq:MDYN); Oculex Pharmaceuticals, Inc.;
Penederm, Inc. (Nasdaq:DERM); Protein Design Labs, Inc.
(Nasdaq:PDLI); RiboGene, Inc.; SangStat Medical Corporation
(Nasdaq:SANG); SEQUUS Pharmaceuticals, Inc. (Nasdaq:SEQU); Shaman
Pharmaceuticals, Inc. (Nasdaq:SHMN); SuperGen, Inc. (Nasdaq:SUPG
and SUPGW); and VIDAMED, Inc. (Nasdaq:VIDA).
"This unique meeting gives investors an opportunity to meet
with a diverse group of biomedical companies in the Bay Area at one
time," said Katharine A. Russell, president of Russell-Welsh Inc.
"The event also highlights the importance of the industry in the
region. With hundreds of companies involved in bioscience and over
50 public biotech companies, the Bay Area has the largest
biotech/bioscience center in the country." Russell-Welsh, Inc., a
communications firm specializing in the life sciences industry, is
providing conference management.
The lead sponsors for the conference are Bowne, Business Wire,
Ernst & Young, Heller Ehrman White & McAuliffe, Silicon Valley Bank,
and Wareham Development Corp.
--30--eh/sf* gdr/sf
CONTACT:
Russell-Welsh Inc.
Angela Bitting, 415/312-0700 Ext. 15 |
